A sex-specific evolutionary interaction between ADCY9 and CETP
- Université de Montréal, Canada
- Montreal Heart Institute, Canada
- Broad Institute, United States
- Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Canada
- Socios En Salud, Peru
Abstract
Pharmacogenomic studies have revealed associations between rs1967309 in the adenylyl cyclase type 9 (ADCY9) gene and clinical responses to the cholesteryl ester transfer protein (CETP) modulator dalcetrapib, however, the mechanism behind this interaction is still unknown. Here, we characterized selective signals at the locus associated with the pharmacogenomic response in human populations and we show that rs1967309 region exhibits signatures of positive selection in several human populations. Furthermore, we identified a variant in CETP, rs158477, which is in long-range linkage disequilibrium with rs1967309 in the Peruvian population. The signal is mainly seen in males, a sex-specific result that is replicated in the LIMAA cohort of over 3,400 Peruvians. Analyses of RNA-seq data further suggest an epistatic interaction on CETP expression levels between the two SNPs in multiple tissues, which also differs between males and females. We also detected interaction effects of the two SNPs with sex on cardiovascular phenotypes in the UK Biobank, in line with the sex-specific genotype associations found in Peruvians at these loci. We propose that ADCY9 and CETP coevolved during recent human evolution due to sex-specific selection, which points towards a biological link between dalcetrapib’s pharmacogene ADCY9 and its therapeutic target CETP.
Data availability
- 1000 Genomes Project, GEUVADIS is freely available.- The Native American genetic dataset was shared to us upon request to the authors of the initial paper and through a data access agreement with Universidad de Antioquia (Prof. Omar Triana Chavez). We contacted bedoya.g@gmail.com and a.ruizlin@ucl.ac.uk to get access to the dataset and we completed a data access application form and signed a data access approval once approved. Applications for access to these data can be submitted at any time. These are considered on a rolling basis and a decision was given within 1 month of receipt. PhD student applicants must include their supervisors as a co-applicant and provide their full contact details. A publication list must be provided for the applicant, co-applicants and PhD supervisors where PhD students have applied to provide proof of competence in handling datasets of this size and nature. - UK Biobank was accessed through data access approval under the project number #15357 and #20168. Information to apply for data access can be found here: https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access - CARTaGENE biobank was accessed through data access approval under the project number #406713. Information to apply for data access can be found here: https://www.cartagene.qc.ca/en/researchers/access-request - GTEx v8 dataset was accessed through dbGaP under project number #19088 LIMAA dataset was accessed through dbGaP under the project number #26882. Information to apply for data access through dbGAP can be found here: https://dbgap.ncbi.nlm.nih.gov- RNA-sequencing of ADCY9-knocked-down HepG2 cell line data has been deposited under GSE174640 (embargo): https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174640For reviewers/editors: Enter token ktaxgqkkrxupjkl into the box- Source data files and code for all main figures are available here: https://github.com/HussinLab/adcy9_cetp_Gamache_2021
-
RNA-sequencing of ADCY9-knocked-down HepG2 cell line (embargo)NCBI Gene Expression Omnibus, GSE174640.
-
LIMAAdbGaP project #26882.
-
Native American genetic dataset (NAGD)rom authors bedoya.g@gmail.com and a.ruizlin@ucl.ac.uk.
Article and author information
Author details
Funding
Institut de Cardiologie de Montréal
- Isabel Gamache
- Marc-André Legault
- Jean-Christophe Grenier
- Rocio Sanchez
- Eric Rhéaume
- Holly Trochet
- Jean-Claude Tardif
- Marie-Pierre Dubé
- Julie Hussin
Université de Montréal
- Isabel Gamache
Canadian Institutes of Health Research
- Marc-André Legault
Canada Research Chairs
- Jean-Claude Tardif
- Marie-Pierre Dubé
Fonds de Recherche du Québec - Santé
- Julie Hussin
Institut de Valorisation des Données
- Isabel Gamache
- Jean-Christophe Grenier
- Julie Hussin
Health collaboration acceleration fund from the Ministère de l'Économie et de l'Innovation of the Government of Quebec
- Jean-Claude Tardif
- Marie-Pierre Dubé
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The analyses done in this study were approved by the different cohorts used. Participants in these cohorts gave their general consent for their data to be used for research purposes. All individual-level data was anonymized and no efforts were made by the authors to deanonymize or recontact any of the participants from the cohorts, in keeping with our agreements with the UK Biobank, CARTaGENE, dbGAP, 1000Genomes and the Native American Genetics dataset (Universidad de Antioquia).
Reviewing Editor
- Ellen Leffler, University of Utah, United States
Publication history
- Received: April 7, 2021
- Preprint posted: May 14, 2021 (view preprint)
- Accepted: October 4, 2021
- Accepted Manuscript published: October 5, 2021 (version 1)
- Version of Record published: November 16, 2021 (version 2)
Copyright
© 2021, Gamache et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 904
- Page views
-
- 85
- Downloads
-
- 6
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
A sex-specific evolutionary interaction between ADCY9 and CETP
eLife 10:e69198.
https://doi.org/10.7554/eLife.69198
Further reading
-
- Computational and Systems Biology
- Neuroscience
Inhibition is crucial for brain function, regulating network activity by balancing excitation and implementing gain control. Recent evidence suggests that beyond simply inhibiting excitatory activity, inhibitory neurons can also shape circuit function through disinhibition. While disinhibitory circuit motifs have been implicated in cognitive processes including learning, attentional selection, and input gating, the role of disinhibition is largely unexplored in the study of decision-making. Here, we show that disinhibition provides a simple circuit motif for fast, dynamic control of network state and function. This dynamic control allows a disinhibition-based decision model to reproduce both value normalization and winner-take-all dynamics, the two central features of neurobiological decision-making captured in separate existing models with distinct circuit motifs. In addition, the disinhibition model exhibits flexible attractor dynamics consistent with different forms of persistent activity seen in working memory. Fitting the model to empirical data shows it captures well both the neurophysiological dynamics of value coding and psychometric choice behavior. Furthermore, the biological basis of disinhibition provides a simple mechanism for flexible top-down control of the network states, enabling the circuit to capture diverse task-dependent neural dynamics. These results suggest a biologically plausible unifying mechanism for decision-making and emphasize the importance of local disinhibition in neural processing.
-
- Computational and Systems Biology
Different strains of a microorganism growing in the same environment display a wide variety of growth rates and growth yields. We developed a coarse-grained model to test the hypothesis that different resource allocation strategies, corresponding to different compositions of the proteome, can account for the observed rate-yield variability. The model predictions were verified by means of a database of hundreds of published rate-yield and uptake-secretion phenotypes of Escherichia coli strains grown in standard laboratory conditions. We found a very good quantitative agreement between the range of predicted and observed growth rates, growth yields, and glucose uptake and acetate secretion rates. These results support the hypothesis that resource allocation is a major explanatory factor of the observed variability of growth rates and growth yields across different bacterial strains. An interesting prediction of our model, supported by the experimental data, is that high growth rates are not necessarily accompanied by low growth yields. The resource allocation strategies enabling high-rate, high-yield growth of E. coli lead to a higher saturation of enzymes and ribosomes, and thus to a more efficient utilization of proteomic resources. Our model thus contributes to a fundamental understanding of the quantitative relationship between rate and yield in E. coli and other microorganisms. It may also be useful for the rapid screening of strains in metabolic engineering and synthetic biology.
